These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


223 related items for PubMed ID: 6159691

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Intra-arterial chemotherapy with nor-adrenaline. Experimental study 1 (enhancement of anti-tumor effect and tumor vessels)].
    Sato T, Katsumi S, Kawaguchi T.
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1245-52. PubMed ID: 3923942
    [Abstract] [Full Text] [Related]

  • 7. Effects of a selective bradykinin B1 receptor antagonist on increased plasma extravasation in streptozotocin-induced diabetic rats: distinct vasculopathic profile of major key organs.
    Lawson SR, Gabra BH, Nantel F, Battistini B, Sirois P.
    Eur J Pharmacol; 2005 May 02; 514(1):69-78. PubMed ID: 15878326
    [Abstract] [Full Text] [Related]

  • 8. The modulation of enhanced vascular permeability by prostaglandins through alterations in blood flow (hyperemia).
    Johnston MG, Hay JB, Movat HZ.
    Agents Actions; 1976 Nov 02; 6(6):705-11. PubMed ID: 1008016
    [Abstract] [Full Text] [Related]

  • 9. Differences in vascular permeability between normal and tumor vessels produced by vasoactive agents.
    Ackerman NB.
    Surg Forum; 1973 Nov 02; 24():105-7. PubMed ID: 4805958
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Mechanisms involved in increasing the vascular permeability under the effect of permeability factors (histamine, serotonin, Bradykinin and inflammatory agents].
    Oĭvin IA, Gaponiuk PIa, Oĭvin VI, Tokarev OIu, Volodin VM.
    Patol Fiziol Eksp Ter; 1972 Nov 02; 16(4):19-23. PubMed ID: 5055441
    [No Abstract] [Full Text] [Related]

  • 14. Effect of histamine on haemorrhagic mucosal lesions is related to vascular permeability in rats: studies with histamine, H1-, H2- and H3-agonists and bradykinin.
    Palitzsch KD, Morales RE, Kronauge JF, Bynum TE, Szabo S.
    Eur J Gastroenterol Hepatol; 1995 May 02; 7(5):447-53. PubMed ID: 7614108
    [Abstract] [Full Text] [Related]

  • 15. [Role of bradykinin and other mediators in acute inflammation with special reference to acceleration capillary permeability as an indicator].
    Nihon Ishikai Zasshi; 1971 Apr 01; 65(7):886-91. PubMed ID: 4324410
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of tobacco smoke on permeability of capillary of pregnant and non-pregnant rats].
    Florek T, Ignatowicz E, Piekoszewski W, Wachowiak A, Wrzosek J.
    Przegl Lek; 2006 Apr 01; 63(10):887-91. PubMed ID: 17288177
    [Abstract] [Full Text] [Related]

  • 17. The response of small blood vessels in rat skin and skeletal muscle to repeated application of histamine: a chemical, topographical and electron microscopic study.
    Jones GM, Hurley JV.
    J Pathol; 1985 Aug 01; 146(4):291-9. PubMed ID: 4032124
    [Abstract] [Full Text] [Related]

  • 18. Suppression by prostaglandin E1 of vascular permeability induced by vasoactive inflammatory mediators.
    Fantone JC, Kunkel SL, Ward PA, Zurier RB.
    J Immunol; 1980 Dec 01; 125(6):2591-6. PubMed ID: 7430639
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.